Oasis Nutraceuticals has informed that a meeting of Board of Directors is scheduled to be held on Thursday, February 14, 2019 at its registered office to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2018. Further, the company informs that, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Securities of the Company will remain closed for all Directors and designated employees of the Company from February 07, 2019 and up to 48 hours from the time of declaration of the financial results / outcome of Board meeting on the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
|Aditya Birla Capital||117.75|
|Shriram Trans. Fin||1167.50|
|L&T Finance Holdings||73.30|
|Mah & Mah Finl. Serv||154.90|